• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Systematic shifts in cystatin C between 2006 and 2010.2006 年至 2010 年间胱抑素 C 的系统变化。
Clin J Am Soc Nephrol. 2011 Aug;6(8):1952-5. doi: 10.2215/CJN.11271210. Epub 2011 Jul 22.
2
Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.尿环孢素 A 和血清胱抑素 C 作为 1 型糖尿病儿童糖尿病肾病的生物标志物。
Pediatr Diabetes. 2020 Aug;21(5):846-855. doi: 10.1111/pedi.13019. Epub 2020 Apr 28.
3
NGAL and cystatin C: two possible early markers of diabetic nephropathy in young patients with type 1 diabetes mellitus: one year follow up.中性粒细胞明胶酶相关脂质运载蛋白(NGAL)和胱抑素C:1型糖尿病年轻患者糖尿病肾病的两种可能早期标志物:一年随访
Hormones (Athens). 2015 Apr-Jun;14(2):232-40. doi: 10.14310/horm.2002.1520.
4
Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.在检测轻度而非重度糖尿病肾病方面,血清胱抑素C比血清肌酐更具优势。
J Intern Med. 2004 Dec;256(6):510-8. doi: 10.1111/j.1365-2796.2004.01414.x.
5
Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes.胱抑素 C 与冠状动脉粥样硬化进展的关系因 1 型糖尿病类型而异。
Diabetes Technol Ther. 2010 Jan;12(1):25-33. doi: 10.1089/dia.2009.0086.
6
Cystatin C for early detection of renal impairment in diabetes.胱抑素C用于糖尿病肾损伤的早期检测。
Clin Biochem. 2009 Jan;42(1-2):108-10. doi: 10.1016/j.clinbiochem.2008.10.002. Epub 2008 Oct 22.
7
Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy.血清胱抑素C可预测2型糖尿病肾病患者的早期预后阶段。
J Clin Lab Anal. 2003;17(5):164-7. doi: 10.1002/jcla.10087.
8
Is serum cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus?血清胱抑素 C 是否可作为准确的内源性肾小球滤过率标志物用于检测 2 型糖尿病患者的早期肾损害?
Ren Fail. 2009;31(5):355-9. doi: 10.1080/08860220902839089.
9
Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.血清尿调蛋白可预测 1 型糖尿病成人在 12 年内冠状动脉钙化和糖尿病肾脏疾病的发生率较低:CACTI 研究。
Diabetes Care. 2019 Feb;42(2):297-302. doi: 10.2337/dc18-1527. Epub 2018 Nov 27.
10
Ability of cystatin C to detect acute changes in glomerular filtration rate provoked by hyperglycaemia in uncomplicated Type 1 diabetes.胱抑素 C 检测单纯 1 型糖尿病高血糖引起的肾小球滤过率急性变化的能力。
Diabet Med. 2010 Dec;27(12):1358-65. doi: 10.1111/j.1464-5491.2010.03121.x.

引用本文的文献

1
Feasibility of replacing Tc-DTPA GFR measurements with eGFR from cystatin C in individuals with spinal cord injuries.在脊髓损伤患者中用胱抑素C估算的肾小球滤过率(eGFR)替代锝-二乙三胺五乙酸(Tc-DTPA)肾小球滤过率(GFR)测量的可行性。
Physiol Rep. 2025 May;13(9):e70315. doi: 10.14814/phy2.70315.
2
Variability in CKD Biomarker Studies: Soluble Urokinase Plasminogen Activator Receptor (suPAR) and Kidney Disease Progression in the Chronic Kidney Disease in Children (CKiD) Study.慢性肾脏病生物标志物研究的变异性:可溶性尿激酶型纤溶酶原激活物受体(suPAR)与儿童慢性肾脏病(CKiD)研究中的肾脏疾病进展
Kidney Med. 2021 Jun 17;3(5):712-721.e1. doi: 10.1016/j.xkme.2021.04.007. eCollection 2021 Sep-Oct.
3
Comparison of mechanisms and transferability of outcomes of SGLT2 inhibition between type 1 and type 2 diabetes.1型糖尿病与2型糖尿病中SGLT2抑制作用机制及结局可转移性的比较
Endocrinol Diabetes Metab. 2020 Apr 24;3(3):e00129. doi: 10.1002/edm2.129. eCollection 2020 Jul.
4
Elevated copeptin, arterial stiffness, and elevated albumin excretion in adolescents with type 1 diabetes.青少年 1 型糖尿病患者中升高的 copeptin、动脉僵硬和白蛋白排泄增加。
Pediatr Diabetes. 2019 Dec;20(8):1110-1117. doi: 10.1111/pedi.12909. Epub 2019 Aug 29.
5
Predictors of early renal function decline in adults with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies.1 型糖尿病成人早期肾功能下降的预测因素:1 型糖尿病冠状动脉钙化和匹兹堡糖尿病并发症流行病学研究。
Diabet Med. 2017 Nov;34(11):1532-1540. doi: 10.1111/dme.13430. Epub 2017 Aug 14.
6
Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: How to measure glomerular filtration rate with iohexol?临床实践和研究中用于测量肾小球滤过率的碘海醇血浆清除率:综述。第1部分:如何用碘海醇测量肾小球滤过率?
Clin Kidney J. 2016 Oct;9(5):682-99. doi: 10.1093/ckj/sfw070. Epub 2016 Aug 23.
7
The Gomez' equations and renal hemodynamic function in kidney disease research.戈麦斯方程与肾脏疾病研究中的肾脏血流动力学功能。
Am J Physiol Renal Physiol. 2016 Nov;311(5):F967-F975. doi: 10.1152/ajprenal.00415.2016. Epub 2016 Sep 7.
8
Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the coronary artery calcification in type 1 diabetes study.估计的胰岛素敏感性可预测1型糖尿病成人患者6年内微血管和大血管并发症的发生:1型糖尿病冠状动脉钙化研究
J Diabetes Complications. 2016 May-Jun;30(4):586-90. doi: 10.1016/j.jdiacomp.2016.02.011. Epub 2016 Feb 11.
9
Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.2型糖尿病青少年的糖尿病肾病:新见解与潜在疗法
Curr Diab Rep. 2016 Feb;16(2):11. doi: 10.1007/s11892-015-0708-0.
10
Update on Estimation of Kidney Function in Diabetic Kidney Disease.糖尿病肾病肾功能评估的最新进展
Curr Diab Rep. 2015 Sep;15(9):57. doi: 10.1007/s11892-015-0633-2.

本文引用的文献

1
A new equation to estimate glomerular filtration rate.一种估算肾小球滤过率的新公式。
Ann Intern Med. 2009 May 5;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006.
2
Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden.用于监测国际临床化学和检验医学联合会(IFCC)糖化血红蛋白参考测量程序与美国、日本和瑞典指定比较方法之间关系的统计方法。
Clin Chem. 2008 Aug;54(8):1379-85. doi: 10.1373/clinchem.2008.103556. Epub 2008 Jun 6.
3
Cystatin C: research priorities targeted to clinical decision making.胱抑素C:针对临床决策的研究重点
Am J Kidney Dis. 2008 Mar;51(3):358-61. doi: 10.1053/j.ajkd.2008.01.002.
4
Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes.血清胱抑素C可预测1型糖尿病患者亚临床冠状动脉粥样硬化的进展。
Diabetes. 2007 Nov;56(11):2774-9. doi: 10.2337/db07-0539. Epub 2007 Jul 27.
5
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values.用标准化血清肌酐值表达肾脏疾病饮食改良研究方程以估算肾小球滤过率。
Clin Chem. 2007 Apr;53(4):766-72. doi: 10.1373/clinchem.2006.077180. Epub 2007 Mar 1.
6
Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.胱抑素C与无慢性肾脏病老年人的心血管及肾脏预后
Ann Intern Med. 2006 Aug 15;145(4):237-46. doi: 10.7326/0003-4819-145-4-200608150-00003.
7
Cystatin C and mortality risk in the elderly: the health, aging, and body composition study.胱抑素C与老年人死亡风险:健康、衰老与身体成分研究
J Am Soc Nephrol. 2006 Jan;17(1):254-61. doi: 10.1681/ASN.2005050545. Epub 2005 Nov 2.
8
Variation in the serum creatinine assay calibration: a practical application to glomerular filtration rate estimation.血清肌酐测定校准的差异:在肾小球滤过率估计中的实际应用。
Kidney Int. 2005 Oct;68(4):1884-7. doi: 10.1111/j.1523-1755.2005.00608.x.
9
Plasma cystatin-C and development of coronary heart disease: The PRIME Study.血浆胱抑素-C与冠心病的发生:PRIME研究
Atherosclerosis. 2006 Apr;185(2):375-80. doi: 10.1016/j.atherosclerosis.2005.06.017. Epub 2005 Jul 25.
10
Cystatin C and the risk of death and cardiovascular events among elderly persons.胱抑素C与老年人的死亡风险和心血管事件
N Engl J Med. 2005 May 19;352(20):2049-60. doi: 10.1056/NEJMoa043161.

2006 年至 2010 年间胱抑素 C 的系统变化。

Systematic shifts in cystatin C between 2006 and 2010.

机构信息

Barbara Davis Center for Childhood Diabetes, University of Colorado-Denver, PO Box 6511, Mail Stop A140, Aurora, CO 80045, USA.

出版信息

Clin J Am Soc Nephrol. 2011 Aug;6(8):1952-5. doi: 10.2215/CJN.11271210. Epub 2011 Jul 22.

DOI:10.2215/CJN.11271210
PMID:21784814
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3156426/
Abstract

BACKGROUND AND OBJECTIVES

Cystatin C is used increasingly as a biomarker of renal function; however, cystatin C assays are not standardized. Our objective was to compare cystatin C results within the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study over time and in repeated measures to evaluate for assay drift.

DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Serum samples were obtained at baseline (visit 1 [V1], 2000 to 2002) and follow-up (visit 2 [V2], 2003 to 2005; visit 3 [V3], 2006 to 2008) and were assayed in 2006 (V1), 2007 to 2008 (V2), and 2010 (V3) in the same laboratory.

RESULTS

Mean cystatin C levels measured using the Dade-Behring assay decreased over time in subjects, with measures at all three visits (V1: 0.80 ± 0.19 [0.42 to 3.41], V2: 0.75 ± 0.22 [0.39 to 3.77], and V3: 0.69 ± 0.22 [0.39 to 3.79]). Cystatin C values were lower in V1 and V2 samples remeasured in 2010 (mean differences -0.13 ± 0.04 and -0.08 ± 0.04, P < 0.0001 for both). Correlations for original and re-run values were strong for V1 (r = 0.99) and V2 (r = 0.99). Deming regression equations and Bland-Altman plots suggest a systematic shift in the values over time.

CONCLUSIONS

Systematic shifts in cystatin C levels, which can be corrected by regression adjustment, occurred in our laboratory in samples measured in 2006 and 2007 to 2008 as compared with 2010. Assay standardization and measurement reliability for cystatin C must be addressed.

摘要

背景和目的

胱抑素 C 作为肾功能的生物标志物的应用日益广泛,但胱抑素 C 检测并未标准化。我们的目的是比较冠状动脉钙化在 1 型糖尿病中的作用(CACTI)研究中随时间推移和重复测量的胱抑素 C 结果,以评估检测漂移。

设计、设置、参与者和测量:于 2000 年至 2002 年(第 1 次就诊 [V1])和 2003 年至 2005 年(第 2 次就诊 [V2])时收集基线血清样本,并于 2006 年(V1)、2007 年至 2008 年(V2)和 2010 年(V3)在同一家实验室进行检测。

结果

使用 Dade-Behring 检测方法测量的胱抑素 C 水平随时间的推移在研究对象中逐渐降低,所有三次就诊(V1:0.80 ± 0.19 [0.42 至 3.41],V2:0.75 ± 0.22 [0.39 至 3.77]和 V3:0.69 ± 0.22 [0.39 至 3.79])的测量值均较低。2010 年重新测量 V1 和 V2 样本时,胱抑素 C 值较低(平均值差异分别为-0.13 ± 0.04 和-0.08 ± 0.04,均<0.0001)。原始值和重新运行值的相关性在 V1(r = 0.99)和 V2(r = 0.99)中均很强。Deming 回归方程和 Bland-Altman 图表明,随着时间的推移,值存在系统偏差。

结论

与 2010 年相比,我们实验室在 2006 年和 2007 年至 2008 年测量的样本中,胱抑素 C 水平发生了系统性变化(可通过回归校正)。必须解决胱抑素 C 的检测标准化和测量可靠性问题。